Yahoo Web Search

  1. Yahoo Finance Results

  2. A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. Eli Lilly and is a member ...

  3. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.

    116.80-0.29 (-0.25%)

    at Wed, Jan 16, 2019, 16:03PM EST - U.S. Markets open in 7 hrs 2 mins

    After Hours 116.30 -0.50 (-0.43%)

    Delayed Quote

    • Open 116.99
    • High 118.07
    • Low 116.48
    • 52 Wk. High 119.84
    • 52 Wk. Low 73.69
    • Mkt. Cap 114.79B
  4. Eli Lilly (LLY) closed the most recent trading day at $115.28, moving +0.54% from the previous trading session. This has was narrower than the Medical sector's loss of 6.76% and ...

  5. Eli Lilly And Co (NYSE: LLY) has become the latest company to have made a move in this direction. Less than e week after Bristol-Myers Squibb Co (NYSE: BMY) clinched ...

  6. Eli Lilly giving price info on advertised drugs via website

    Associated Press via Yahoo FinanceJan 08 22:27 PM

    Drugmaker Eli Lilly has started posting price information online for drugs advertised on TV. On Tuesday, the company began running TV ads for a popular diabetes drug that ...

  7. Why Eli Lilly Is Buying Loxo Oncology for $8 Billion

    Motley Fool via Yahoo FinanceJan 08 22:01 PM

    Eli Lilly and Co. (NYSE: LLY) is best known as the maker of top-selling diabetes medications, including the popular Humalog insulin, but it's also a big player in cancer ...

  8. Forget GlaxoSmithKline, Eli Lilly Is a Better Big Pharma Stock

    Motley Fool via Yahoo FinanceDec 29 13:02 PM

    While some eyes were on Glaxo, Eli Lilly (NYSE: LLY) has successfully assembled one of the most impressive new-product lineups in the business.

  9. Eli Lilly to Buy Loxo Oncology for $8 Billion

    Bloomberg via Yahoo FinanceJan 07 14:53 PM

    The purchase is Indianapolis-based Lilly’s biggest takeover ever, according to data compiled by Bloomberg. The Stamford, Connecticut-based biotechnology company is developing cancer ...

  10. Is Eli Lilly Overpaying for Loxo Oncology?

    Motley Fool via Yahoo FinanceJan 08 13:46 PM

    Eli Lilly (NYSE: LLY) shares finished Monday on a slightly positive note after the company announced an agreement to acquire Loxo Oncology (NASDAQ: LOXO) for $8 billion ...

  11. Biotech ETFs Surge After Eli Lilly Buys Out Loxo Oncology

    ETF Trends via Yahoo FinanceJan 07 18:56 PM

    Biotechnology stocks and sector-related ETFs were among the best performers Monday after Eli Lilly (LLY) said it will acquire Loxo Oncology Inc. LOXO) for $8 billion. Among ...